Liminatus Pharma, Inc. (LIMN) › Weighted Average Diluted SharesLiminatus Pharma, Inc. (LIMN) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2024-12-31: 17.50M2025-12-31: 23.75M23.75M2024-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3123.75M+35.7%2026-03-31From 2025-01-012024-12-3117.50M—2026-03-31From 2024-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)